Literature DB >> 2293220

Release of human serum albumin from poly(lactide-co-glycolide) microspheres.

M S Hora1, R K Rana, J H Nunberg, T R Tice, R M Gilley, M E Hudson.   

Abstract

Human serum albumin (HSA) was encapsulated in a 50:50 copolymer of DL-lactide/glycolide in the form of microspheres. These microspheres were used as a model formulation to study the feasibility of controlling the release of large proteins over a 20- to 30-day period. We show that HSA can be successfully incorporated into microspheres and released intact from these microspheres into various buffer systems at 37 degrees C. A continuous release of the protein could be achieved in physiological buffers at 37 degrees C over a 20- to 30-day period from microspheres with high protein loadings (11.6%). These results demonstrate the potential of poly(DL-lactide-co-glycolide) microspheres for continuous delivery of large proteins.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2293220     DOI: 10.1023/a:1015948829632

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  15 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Chemical modification of recombinant interleukin 2 by polyethylene glycol increases its potency in the murine Meth A sarcoma model.

Authors:  N V Katre; M J Knauf; W J Laird
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

3.  Controlled release of insulin from polymer matrices. In vitro kinetics.

Authors:  L Brown; L Siemer; C Munoz; R Langer
Journal:  Diabetes       Date:  1986-06       Impact factor: 9.461

4.  Poly(lactide-co-glycolide) microcapsules for controlled release of steroids.

Authors:  D R Cowsar; T R Tice; R M Gilley; J P English
Journal:  Methods Enzymol       Date:  1985       Impact factor: 1.600

5.  Controlled release and magnetically modulated release systems for macromolecules.

Authors:  R Langer; L Brown; E Edelman
Journal:  Methods Enzymol       Date:  1985       Impact factor: 1.600

6.  New developments in isoelectric focusing.

Authors:  P G Righetti; E Gianazza
Journal:  J Chromatogr       Date:  1980-11-07

7.  Controlled release of a luteinizing hormone-releasing hormone analogue from poly(d,l-lactide-co-glycolide) microspheres.

Authors:  L M Sanders; J S Kent; G I McRae; B H Vickery; T R Tice; D H Lewis
Journal:  J Pharm Sci       Date:  1984-09       Impact factor: 3.534

8.  Altered pharmacological properties of liposome-associated human interferon-alpha.

Authors:  D A Eppstein; W E Stewart
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

9.  Sustained drug delivery systems II: Factors affecting release rates from poly(epsilon-caprolactone) and related biodegradable polyesters.

Authors:  C G Pitt; M M Gratzl; A R Jeffcoat; R Zweidinger; A Schindler
Journal:  J Pharm Sci       Date:  1979-12       Impact factor: 3.534

10.  Glucose-sensitive membranes containing glucose oxidase: activity, swelling, and permeability studies.

Authors:  J Kost; T A Horbett; B D Ratner; M Singh
Journal:  J Biomed Mater Res       Date:  1985 Nov-Dec
View more
  34 in total

Review 1.  Protein instability in poly(lactic-co-glycolic acid) microparticles.

Authors:  M van de Weert; W E Hennink; W Jiskoot
Journal:  Pharm Res       Date:  2000-10       Impact factor: 4.200

2.  Single-dose mucosal immunization with biodegradable microparticles containing a Schistosoma mansoni antigen.

Authors:  B Baras; M A Benoit; L Dupré; O Poulain-Godefroy; A M Schacht; A Capron; J Gillard; G Riveau
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  Treatment of tuberculosis using a combination of sustained-release rifampin-loaded microspheres and oral dosing with isoniazid.

Authors:  D C Quenelle; G A Winchester; J K Staas; E L Barrow; W W Barrow
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

4.  Efficacy of microencapsulated rifampin in Mycobacterium tuberculosis-infected mice.

Authors:  D C Quenelle; J K Staas; G A Winchester; E L Barrow; W W Barrow
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

5.  Solvent exchange method: a novel microencapsulation technique using dual microdispensers.

Authors:  Yoon Yeo; Alvin U Chen; Osman A Basaran; Kinam Park
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

6.  Sustained cytoplasmic delivery and anti-viral effect of PLGA nanoparticles carrying a nucleic acid-hydrolyzing monoclonal antibody.

Authors:  Yoon Ki Joung; Sejin Son; Ji Young Jang; Myung Hee Kwon; Ki Dong Park
Journal:  Pharm Res       Date:  2011-12-03       Impact factor: 4.200

7.  Biodegradable microparticles as controlled release antigen delivery systems.

Authors:  D T O'Hagan; D Rahman; J P McGee; H Jeffery; M C Davies; P Williams; S S Davis; S J Challacombe
Journal:  Immunology       Date:  1991-06       Impact factor: 7.397

8.  Characterization of reservoir-type microcapsules made by the solvent exchange method.

Authors:  Yoon Yeo; Kinam Park
Journal:  AAPS PharmSciTech       Date:  2004-09-17       Impact factor: 3.246

9.  Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles.

Authors:  K J Maloy; A M Donachie; D T O'Hagan; A M Mowat
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

10.  Process variable implications for residual solvent removal and polymer morphology in the formation of gentamycin-loaded poly (L-lactide) microparticles.

Authors:  R F Falk; T W Randolph
Journal:  Pharm Res       Date:  1998-08       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.